检验医学与临床
檢驗醫學與臨床
검험의학여림상
Laboratory Medicine and Clinic
2015年
17期
2614-2615,2618
,共3页
胸腺五肽%术后早期炎性肠梗阻%临床研究
胸腺五肽%術後早期炎性腸梗阻%臨床研究
흉선오태%술후조기염성장경조%림상연구
thymopentin%EPISBO%clinical research
目的:探讨胸腺五肽治疗术后早期炎性肠梗阻的临床效果。方法收集2013年10月至2014年10月3家医院76例术后早期炎性肠梗阻患者的临床资料,随机分为试验组与对照组,每组各38例。对照组采取禁食、胃肠减压、生长抑素、肠外营养等常规治疗方法,研究组在对照组治疗基础上加以胸腺五肽治疗,并对比分析两组间的治疗效果。结果经治疗,两组患者均痊愈。试验组不良反应发生率稍高于对照组,但差异无统计学意义(P>0.05)。试验组患者肠鸣音恢复时间、肛门排气时间、拔除胃管时间、治愈时间明显低于对照组,差异有统计学意义(P<0.05)。结论胸腺五肽用于治疗术后早期炎性肠梗阻,可明显缩短患者治疗时间,减轻患者痛苦,无明显不良反应,值得临床推广。
目的:探討胸腺五肽治療術後早期炎性腸梗阻的臨床效果。方法收集2013年10月至2014年10月3傢醫院76例術後早期炎性腸梗阻患者的臨床資料,隨機分為試驗組與對照組,每組各38例。對照組採取禁食、胃腸減壓、生長抑素、腸外營養等常規治療方法,研究組在對照組治療基礎上加以胸腺五肽治療,併對比分析兩組間的治療效果。結果經治療,兩組患者均痊愈。試驗組不良反應髮生率稍高于對照組,但差異無統計學意義(P>0.05)。試驗組患者腸鳴音恢複時間、肛門排氣時間、拔除胃管時間、治愈時間明顯低于對照組,差異有統計學意義(P<0.05)。結論胸腺五肽用于治療術後早期炎性腸梗阻,可明顯縮短患者治療時間,減輕患者痛苦,無明顯不良反應,值得臨床推廣。
목적:탐토흉선오태치료술후조기염성장경조적림상효과。방법수집2013년10월지2014년10월3가의원76례술후조기염성장경조환자적림상자료,수궤분위시험조여대조조,매조각38례。대조조채취금식、위장감압、생장억소、장외영양등상규치료방법,연구조재대조조치료기출상가이흉선오태치료,병대비분석량조간적치료효과。결과경치료,량조환자균전유。시험조불량반응발생솔초고우대조조,단차이무통계학의의(P>0.05)。시험조환자장명음회복시간、항문배기시간、발제위관시간、치유시간명현저우대조조,차이유통계학의의(P<0.05)。결론흉선오태용우치료술후조기염성장경조,가명현축단환자치료시간,감경환자통고,무명현불량반응,치득림상추엄。
Objective To observe the clinical efficacy of thymopentin in the treatment of early postoperative inflammatory small bowel obstruction(EPISBO) .Methods The clinical data in 76 cases of EPISBO were collected from 3 hospitals October 2013 to October 2014 .The patients were divided into the experimental group and the control group ,38 cases in each group .The control group were treated with the routine treatment way including fasting ,gas‐trointestinal decompression ,somatostatin and parenteral nutrition ,while on this basis the experimental group was added with thymopentin .Then the clinical effects were analyzed and compared between the two groups .Results All patients in the two groups were cured after treatment .The occurrence rate of adverse reactions in the experimental group was slightly higher than that in the control group without statistical difference between them (P>0 .05) .The bowel sounds recovery time ,anal exhausting time ,gastric tube extubation time and cure time in the experimental group were significantly shorter than those in the control group ,the differences were statistically significant(P<0 .05) .Conclusion Thymopentin for treating EPISBO can significantly shorten the treatment time ,alleviates the pa‐tients suffering ,has no obvious adverse reactions ,and is worthy being clinically promoted .